Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi.

Nawal Al KaabiYunkai YangSalah Eldin HusseinTian YangJehad AbdallaHui WangZhiyong Lounull Chinese Center For Disease Control And PreventionAgyad BakkourAfnan Arafatnull China National Biotec Group Company LimitedZhiwei JiangYe Tiannull National Engineering Technology Research Center For Combined Vaccines Wuhan Institute Of Biological Products Co Ltdnull Beijing Institute Of Biological Products Company LimitedPeng XiaoWalid ZaherIslam EltantawyChenlong WangGuangxue XuYuntao ZhangXiao Ming Yang

Published in: Vaccines (2023)

This study is registered on ClinicalTrials.gov (NCT04510207).

Keyphrases

placebo controlled
double blind
sars cov
phase iii
phase ii
open label
clinical trial
study protocol
respiratory syndrome coronavirus
randomized controlled trial
phase ii study
squamous cell carcinoma
coronavirus disease